The role of your cancer health professional is to create an
environment of openness and trust, and to help in making
informed decisions about alternative/complementary therapies.
Collaboration will improve the safe integration of all therapies
during your experience with cancer. The "Summary" and
"Professional Evaluation / Critique" sections of this
Unconventional manual are cited directly from the medical
literature, and are intended to help in the objective evaluation
of alternative/complementary therapies.

Summary

"Its formulation and administration are based on unconventional
views about the nature of cancer that have not been
substantiated by mainstream researchers. Side effects appear to
be minimal, but evidence of its effectiveness is limited."
(Kaegi)

Description / Source / Components

"714-X is the name given to an alternative product developed by
Gaston Naessens, a French microbiologist now residing in Quebec,
Canada." (Cassileth)

"Camphor is a natural product derived from the shrub Cinnamomum
camphora." (Kaegi)

714X is injected daily (perinodular). A series of shots
consists of twenty-one daily injections; three such series are
the minimum required, but most patients should expect to undergo
longer-term treatment." (Fink 1997)

714X must be "injected intralymphatically via a lymph node in
the groin." (Davies)

This product may be requested by physicians on compassionate
plea under the Emergency Drug Release Program. The authorization
only provides legal access to the drug and does not ensure or
imply approval of the quality, manufacturing process or clinical
use. (Health) (714X)

"Outside Canada, 714-X is available in Mexico and Western
Europe but not in the US, where it is currently under
investigation by the Food and Drug Administration." (Kaegi)

History

Naessens claims to have developed in the 1940s "an extremely
powerful light microscope (it uses ultraviolet and laser
technology) that is capable of extraordinary rates of
magnification -- up to 30,000X -- and can examine living
tissue." (Davies)

"(The later development of the electron microscope, which
allows even higher magnification [although not of fresh,
unstained blood and tissues], displaced interest in the
somatoscope and other similar microscopes that used dark-field
microscopy.)" (Kaegi)

Gaston Naessens "was arrested in Quebec in 1989 and charged
with four counts of illegal practice of medicine and one count
of contributing to the death of a patient." (Roberts)

"Naessens had been convicted four times of practicing medicine
without a license, twice in France, and twice in Canada."
(Blackburn)

"The name `714-X' reflects Naessens' pride in his creation. The
numbers `7' and `14' represent the seventh and fourteenth
letters in the alphabet (Naessens' initials), and the `X', the
24th letter in the alphabet, represents the year of his birth
(1924)." (Kaegi)

Proponent / Advocate Claims

"Gaston Naessens hypothesizes that all living beings, animal
and vegetable, possess life by virtue of microscopic dense
particles that he calls 'somatids'. His unique approach to
studying morphological correlates of health from blood samples
relies on using his Somatoscope and Ultramicroscope to view the
abnormal cycle of the somatids in the blood (orthodox medicine
has no live blood test for cancer). ... The centre [Cose Inc.]
believes that cancer development is related to a lowering of
inhibitors (e.g. chalones) transported in the blood." (Fink
1997)

"He [Naessens] believed somatids to be living organisms
distinct from bacteria and viruses, and he described 2 distinct
life cycles for these organisms: a 'microcycle' consisting of 3
forms, which he observed in healthy individuals, and a more
complex 'macrocycle' consisting of 16 forms which he usually
observed in individuals with degenerative diseases, including
cancer. He reports that at the different stages of the cycle,
the form of the somatids may resemble bacteria, yeasts or fungi.
He claims to be able to diagnose and monitor disease processes
by observing the number and forms of somatids in the blood."
(Kaegi)

Naessens believed that "if the somatids are exposed to some
sort of trauma (e.g. pollution, radiation), then they enter a
wild uncontrolled growth cycle which leads to cancer." The 714X
is supposed to return the somatids to a normal state. (714X)

"He used the somatoscope routinely to determine whether
treatment with 714-X, a mixture of nitrogen and camphor (to
deliver the nitrogen), was working for each particular patient.
Naessens theorized that cancer cells are deficient in nitrogen,
and that injecting 714-X into the lymph system would convert
them to normal cells." (Cassileth)

"The goal is to fluidify the lymph, and to direct nitrogen to
the cancerous cells in order to stop their toxic secretions,
which block the organism's defense mechanism." (Fink 1997)

"Naessens selected camphor as the base because he believes it
has special affinity for cancer cells. ... Naessens included
ammonium salts because he believes they improve the circulation
of lymph in cancer patients. He also believes that the ammonium
salts activate certain kinins that inhibit abnormal cell growth
and enhance the healthy functioning of the immune system."
(Kaegi)

"Recently, the distributors have advised that 714-X can
sometimes be administered nasally using a nebulizer containing a
solution of 0.6 mL of 714-X in 1.9 mL of saline. The nasal route
has been recommended for patients with lung or oral cancers."
(Kaegi)

"Dr. Atkins cautions that patients undergoing the 714X
treatment should not take therapeutic doses of vitamin E or
vitamin B12 at the same time, as the two vitamin supplements may
interfere with its therapeutic action." (Diamond)

Professional Evaluation / Critique

"There is no scientific evidence in support of the efficacy of
this method." (Cassileth)

"Naessens's theories about the underlying causes and mechanisms
of cancer are clearly not consistent with current scientific
opinion. Although a small number of researchers have long
believed that certain bacteria, viruses and other organisms such
as cell-wall deficient or pleomorphic bacteria play a much more
important role in the development of cancer, this view is not
generally accepted by mainstream scientists." (Kaegi)

"There have been few published animal studies of the safety and
effectiveness of 714-X, and those that have been conducted have
shown no beneficial effect." (Kaegi)

"It is safe to say that the 'microscope invention' is a
hodge-podge of different physics phenomena, which either are
non-existent and certainly cannot be demonstrated to exist in
any laboratory of a reputable university or any other similar
institution (e.g. two wavelengths combining to produce a third
wavelength), or a known physics phenomena which do exist (e.g.
Zeeman effect) but do not act at all as described by this man.
If the rest of his "discoveries" in any way resemble the
microscope 'discovery', then I must conclude that his whole
theory of somatids and immune system booster compound 714-X and
their role in cancer diagnosis and treatment has no value."
(Palcic)

"A few animal studies using extracts of the shrub C. camphora,
which is the natural source of camphor, have demonstrated some
evidence of biological activity of potential value in the
treatment of cancer. ... However, research into the effects of
camphor remains at an early stage." (Kaegi)

Toxicity / Risks

714X has no (reported) side effects but should be used only
with the supervision of a physician. (Fink 1988)

The administration is complex. 714X must be given
intra-lymphatically into a lymph node in the groin every day for
21 days. The container vial is expected to be used for several
treatments and no information on preservatives or stability of
714X given. Vials must be stored in the refrigerator.
(Nakashima)

"714X has no harmful side effects, other than burning
sensations at or around the site of injection." (Diamond)

"Taken internally, camphor may have serious toxic effects."
(Kaegi)

Costs

A series of injections cost approximately $350 Cdn. (Ontario,
1994)

It costs $320 U.S. for one series of shots consisting of 21
daily injections. Included with the medicine are a protocol,
injection instructions, and a videocassette on the treatment.
(Fink 1997)

In Canada, 714X is reported to cost $69.55 for 2 vials of 5 mL
in 1993. (Nakashima, 1996)

Fink JM. Third Opinion: an international directory to
alternative therapy centers for the treatment and prevention of
cancer and other degenerative diseases. 2nd ed. Garden City
Park, New York: Avery Publishing Group Inc., 1988:47.

Fink JM. Third opinion: an international directory to
alternative therapy centers for the treatment and prevention of
cancer and other degenerative diseases. 3rd ed. Garden City
Park, New York: Avery Publishing Group Inc., 1997:67.

Kaegi E, on behalf of the Task Force on Alternative Therapies
of the Canadian Breast Cancer Research Initiative.
Unconventional therapies to cancer: 6. 714-X. Canadian Medical
Association 1998;158:1621-1624.

714X is manufactured by the private laboratory Centre
expérimental de recherches biologiques de l'Estrie Inc.
(C.E.R.B.E. inc.). The product is exclusively distributed
by CERBE Distribution Inc. and its authorized agents.

714X developed for perinodular injections (basic treatment)

This product is available in 6.5 ml vials. Two vials are
required to complete 21 consecutive days of treatment referred
to as one cycle. This basic treatment is directly administered
into the large lymphatic circulation (See Section J).

714X developed for inhalation through the respiratory tract
(secondary treatment, if necessary).

The secondary treatment of 714X is performed with the use of a
medical device known as a nebulizer. This treatment is added to
reach the smaller segment of the lymph system known as the small
lymphatic circulation.

* The absence of proteins and immunoglobulins shows that 714X
is not an immune serum prepared after injection to
animals. 714X is not a vaccine.

* The presence of sodium chloride at a level of 8.2 g/liter
shows that it is an isotonic solution having a pH=7
(physiological solution). This solution complies with
norms for injectable solutions of the pharmaceutical industry.

* The gas chromatography coupled with the mass spectrometry
reveals the presence of camphor or trimethyl-(1.7.7) bicyclo
(2.2.1.) heptanone-2 that we have quantified. Its
concentration is 0.09 mg/ml (90 ppm). A nitrogenated
compound and hydrochloric acid were also detected.

* The test using the camphoroxime that was synthesized shows
that this molecule does not exist as such in the sample of 714X
analyzed. The nitrogenated compound could not be clearly
identified with the testing done.

* Eighteen metals have been measured. They all are at trace
levels, of the order of ppm (parts per million) and are without
biological significance, except magnesium, whose level of 6.5
ppm is still with no therapeutic significance. (This is the
opinion of the laboratory. However, the manufacturer claims that
the trace levels identified do have a biological significance.)

714X is not designed to destroy diseased cells.

714X is a product created to improve health by revitalizing the
immune system and is not designed to directly act on disease
related symptoms.

The particular method of administration of the product makes it
unique.

A brief overview of the physiology of the lymph system is
necessary given 714X's method of administration :

Most of the constituting elements of blood plasma flow freely
through the capillary walls to form the interstitial fluid.
Blood capillaries lose more fluid through filtration than they
recover through reabsorption. The excess fluid filtered through
the blood system (approximately 3 liters per day) penetrates the
lymphatic capillaries where it creates the lymph.

The resulting lymph then flows in parallel to the large blood
circulation. The lymph is then discharged into the venous blood
(that is the blood which brings waste matter to the heart) at
the junction of the sub-clavicle veins and the internal jugular
veins in the neck area.
The lymphatic system is comprised of the lymph, the lymphatic
vessels in which the lymph flows and many structures and organs
which contain lymphatic tissue and bone marrow where lymphocytes
are produced.

The lymphatic system fills several roles :

1. It drains interstitial fluids. The lymphatic vessels drain
any excess interstitial fluids located between the cells. This
liquid once collected in the lymphatic vessels is called the
lymph.

2. It carries away the digestive fats. The lymphatic vessels
transport the various fats and liposoluble vitamins absorbed by
the digestive tube.

3. It protects the organism against foreign bodies. The
lymphatic tissue triggers immune responses. These responses are
specific to bacteria, viruses or immature cells. The lymphocytes
(a type of white blood cell that creates antibodies) with the
help of macrophages, detect foreign bodies, microbes, viruses
and immature cells such as cancerous cells.

From an anatomical point of view, nature has provided the body
with a double lymphatic circulation. These two circulations,
which do not communicate with each other, act in a closed
circuit. Never touching each other, they nonetheless both
discharge into the blood stream (See adjoining diagram).

The large lymphatic circulation drains 75 % of the body, being
the lower left and right sides of the body as well as the upper
left side of the body.

The small lymphatic circulation drains 25 % of the body being
the upper right side of the body.

To access the large lymphatic circulation, 714X must be
introduced by way of perinodular injections into the right
inguinal area.

To access the small lymphatic circulation, an ultrasonic
nebulizer must be used to allow the nodes located in the
respiratory tract to absorb 714X .

When introduced into the lymphatic system, 714X acts in three
ways :

1. It liquefies the lymph, meaning that it renders the lymph
more fluid and capable of easier circulation (better able to
assure draining of cellular toxins).

This fluidifying action of 714X is produced by the sodium and
ammonium chlorides contained in the product. A fluidified
lymph can once again insure elimination of toxins and trigger
appropriate immune responses.

N.B. : Clinical observations using a lymphograph revealed that
the lymph of a person afflicted with a degenerative disease is
both thick and stagnant. It does not flow freely.
This observation raised the hypothesis that the lack of fluidity
in the lymph can be a biological precursor to degenerative
diseases.

2. It brings nitrogen to the organism as an active ingredient.
Nitrogen is a fundamental element to the creation of living
matter : it is also an essential element to cellular
repair. It is carried to the blood stream by the lymphatic
circulation.

Where cancer is present (uncontrolled immature cell division)
immature cells reach a critical mass that requires nitrogen to
develop. These cells then secrete a substance which
paralyses the immune system so that they can then get their
required nitrogen from healthy cells.

A vicious cycle then is established which supports the growth
of cancerous cells while the immune system is unable to act.

By bringing nitrogen to the immature cells, 714X stops the
secretion of the paralyzing factor by the immature cells thus
allowing the immune system to recover its natural functions.

3. 714X brings 18 trace elements to the system thus promoting
intercellular communications. The trace elements contained in
714X facilitate inter and intra cellular communications,
necessary exchanges that may have been temporarily interrupted
or blocked by the progressive clogging up of a stagnating lymph.

714X acts directly on the lymph to restore its immune activity.

By its direct action on the lymph and its arrival into the
blood stream (once mixed with the lymph), 714X normalizes the
biological functions related to homeostasis. It is a product
which harmonizes the biochemical reactions involved in normal
cellular development, in tissue repair and in the body's
specific and non-specific defense mechanisms.

714X's therapeutic effects can be summarized in two ways :

1. An increase in the body's natural defense mechanisms, that
is, the non-specific immune defense mechanisms that act upon
foreign bodies such as bacteria and viruses. Natural defense
mechanisms include the skin, the mucous membranes, the
anti-microbial chemical reactions, phagocytosis by neutrophiles,
inflammation and fever mechanisms.

2. An increase in the specific immune responses principally
assured by lymphocytes (B and T) and macrophages which acting
together detect cells and foreign bodies, germs and cancerous
cells flowing through the body. These immune responses are
triggered to establish contact with foreign substances, destroy
them and then eliminate them so that they will not impede the
normal metabolic functions of the body's organs. 714X thus
allows a weakened organism the opportunity to regain its defense
mechanisms and therefore enhance the process of cellular repair.

714X is a non-toxic treatment which supports the body's natural
defense mechanisms. It is compatible with most therapeutic
approaches seeking to bolster the biological terrain. These
therapies are generally referred to as non-conventional,
complimentary, alternative, etc.

Clinical observations have revealed certain exceptions in the
case of :

These exceptions apply to dietary supplements but do not
include vitamins B-12 and E found in food.

Vitamin B12

It is recommended not to simultaneously use 714X and vitamin
B12 supplements.

Vitamin B12 accelerates cellular division (especially blood
cells) without distinguishing healthy cells from immature
cells. There is nothing to be gained by stimulating cell
division in an already hyperactive organism. This
restriction does not affect vitamin B12's properties in a normal
context.

For those persons having had a partial or total removal of the
small intestine who wish to take 714X, the above exception
concerning vitamin B12 does not apply as this vitamin is
essential for such persons' survival.

Vitamin E

It is not recommended to use 714X and vitamin E supplements
simultaneously.

It is a recognized fact that vitamin E protects cellular
membranes against free radicals. This antioxidant property of
vitamin E is important in the prevention of cancer, but once
cancer has taken hold of the organism, this vitamin could create
a protective coating around immature cells and thus delay their
identification and elimination by the immune system.

Shark and bovine cartilage

It is not recommended to use 714X and shark or bovine cartilage
or antiangiogenic products (products aiming at shrinking blood
vessels) simultaneously

Shark cartilage seeks to asphyxiate a tumoral mass by stopping
its vascularisation process. This is a valid approach if one
considers cancer as a localized problem.

However, if one considers cancer as a generalized disease which
localizes itself in a vulnerable area of the body, it becomes
useless to act locally if the defense mechanisms are not
supported. In this approach, the tumor is only confirmation of a
more profound problem.

Shark cartilage is incompatible with 714X as 714X requires a
good blood circulation so that the body may eliminate tumoral
masses.

714X is not toxic and does not destroy diseased cells. It only
supports the body's natural defense mechanisms and its immune
system. It can be used with conventional treatments whether they
be chemotherapy, surgery, radiation therapy or other therapies.
It does not hinder their respective modes of action nor does it
modify their effectiveness. 714X combined with conventional
therapies can only benefit the patient as it promotes the
elimination of metabolic waste matter (meaning toxins) produced
by the above mentioned conventional treatments. It can also
reduce the intensity of certain side effects associated with
conventional therapies such as nausea, loss of appetite, etc. as
it helps the body to cleanse itself by favoring the circulation
of the lymph and by assisting in cellular repair by bringing
nitrogen to the organism.

Manufacturer's recommendation

If surgery is to occur and the patient's life is not in any
immediate danger, it is recommended that a full 21 consecutive
day course of 714X be done prior to surgery. This procedure can
only assist the organism by promoting a strong local and
systemic immune response.

For those cancer patients requiring surgery, the above
recommendation becomes even more important as it reduces the
risks of spreading cancer to a new site (metastasis), given that
surgery can assist the migration of cancerous cells via the
lymphatic system.

714X may be used for preventive purposes. In such cases, one to
three consecutive cycles of perinodular injections are
recommended.

When dealing with a degenerative disease confirmed by a medical
diagnosis, 714X may be used by itself or in conjunction with
other treatments. In these cases, a minimum of 6 to 8
consecutive cycles of injections are required. In some cases,
continued use may be necessary even though 714X was not
conceived as a lifelong medication.

The quantity of product to be injected as well as the frequency
of the injections appears in the adjacent calendar :

It is pointless to increase daily doses in the hope of speeding
up the healing process. The recommended dosages have been
clinically determined and remain those having afforded the best
results.

1. Progressive doses are administered during the first five
days of the first cycle beginning with 0.1 ml. on day one, 0.2
ml on day two and so on until day five. This progression is
necessary to avoid overtaxing the elimination organs due to the
increased number of toxins being eliminated once the lymph
becomes more fluid.

2. From day five of the cycle to day twenty-one, the daily dose
will be 0.5 ml.

3. Each twenty-one day cycle must be followed by two days with
no injections being performed to allow the organism to rest.

4. The second and all subsequent cycles will consist of 0.5 ml
injections from day one to day twenty-one inclusively.

5. Children weighing less than 30 kg (66 pounds) will receive
one half of the daily dose prescribed for adults but will also
complete full twenty-one day cycles.

Ultrasonic nebulizer treatments

Ultrasonic nebulizer treatments require a special mixture of
714X which has a different molecular weight than the injectable
product. The nebulizer product is packaged in 2 ml ampoules,
seven ampoules being included in each box. Three boxes are
required for a 21 day cycle.

The nebulizer treatment is a secondary treatment which begins
only during the second injection cycle. A 12 hour interval is
required between the injections and the inhalations by way of
the nebulizer. Some people prefer injecting in the morning while
others prefer the evening. This depends on each person's
tolerance and routine. From a biological standpoint, there
is no difference. It remains a strictly personal choice.

Side effects are generally understood to mean foreseeable and
harmful side effects present amongst all users. Such effects are
not systematically found in people using 714X.

To the contrary, using 714X can increase the quality of life of
its users (increased vitality and pain threshold, better
appetite, less stress, etc.). Each person's constitution as well
as their body's need for cleansing and cellular repair will be
factors influencing how 714X acts upon them. Each person is
different. It is most difficult to gage 714X's impact from one
person to another.

Occasionally, during the first treatment cycle, certain
observations will confirm that the cellular cleaning process has
begun. Most users do not notice any particular changes except
for improved activity in the elimination organs (bladder,
intestines, lungs).

It is recommended however to strictly apply the utilization
protocol of 714X to avoid any discomforts which may result from
a rapid application of the product.

Conclusion

714X is a health product conceived and manufactured to support
the body's natural defenses. The method chosen to achieve this
objective is the liquifying of the lymph. Once liquefied, the
lymph can resume its normal draining functions as well as its
other immunological properties.

714X is easily absorbed by the body : it sustains life by
bringing to the organism fundamental elements such as nitrogen
(brought to the system by the camphor molecule) and a variety of
trace elements.

714X is non-toxic. It produces no harmful side effects. It may
be used in a preventive mode. It is recommended for those people
suffering from some sort of immune deficiency or degenerative
disease confirmed by a medical diagnosis.

The Lymphatic Pathway

US Patent # 6,596,295Aqueous Solution for Treating Degenerative
or Autoimmune Diseases and/or as an Immunomodulatory Agent

22 July 2003US Cl. 424/422

Gaston NAESSENS

Abstract -- The invention concerns an aqueous solution
capable of being injected by perinodular delivery or inhaled for
use in the treatment of degenerative or autoimmune diseases or
as immunomodulatory agent. Said solution is prepared by reacting
camphor on ammonium hydroxide. The resulting product is then
suspended in a saline solution. Said preparation having a basic
pH is then neutralized with nitric acid. The resulting aqueous
solution has pharmacological properties since it is an analogue
of human cytokines, which makes it useful for treating
degenerative or autoimmune diseases and/or as an
immunomodulatory agent.

Foreign Patent DocumentsGB 385,148 (1932) // WO 97 05780

Description

The present invention relates to an aqueous solution that is
administrable by perinodular injection or by inhalation and is
usable for treating degenerative or autoimmune diseases and/or
as an immunomodulatory agent.

The invention also relative to a method for preparing this
solution.

This method is characterized in that: in a first step, camphor
is reacted with ammonium hydroxide; in a second step, the
product obtained in the first step is suspended in an aqueous
solution of sodium chloride; and in a third step, the pH of the
liquid suspension obtained in the second step is neutralized
with nitric acid to obtain the desired aqueous solution.

The aqueous solution according to the invention as obtained by
the method described above, has been thoroughly tested and has
proven to have pharmacological properties which make it
efficient for the treatment of degenerative or autoimmune
diseases and/or as an immunomodulatory agent.

Thus, it has been noticed that it mimicks human cytokines.
Thus, it acts on monocytes to transform them into macrophages
which, in turn, secrete two proinflammatory cytokines:
interleukin 1 beta, 6, 8.alpha. and a tumor necrosis factor TNF
alpha. Depending on the mimicked cytokine family, monocytes are
transformed into macrophages or block molecules which paralyse
the immune system. In both cases, a stimulation of the immune
system and an increase in the tumor necrosis factor, which is
also classified among immunostimulating factors, occur. This
factor is also known for the role it plays in host resistance
against viral infections or others, and in tumor development.

Based on testings performed on animals, the solution according
to the invention would be applicable in human therapeutics using
0.075 ml per pound of body weight for 21 days, that is to say a
total of 10.5 ml per series, which corresponds to 0.5 ml per day
for a person weighing 140 pounds. Administration can be done by
perinodular injection or by inhalation with an ultrasonic
nebulizer.

For a person of 140 to 190 pounds, the first series should be
applied in a progressive way according to the following
schedule:

All the other injections should comprise the same volume (0.5
ml) of injected product.

The following series will use 0.5 ml at each injection for 21
days.

Cycles can be repeated if needed with an interruption of 2 days
between each cycle.

The structure of the active principle present within the
aqueous solution according to the invention has not been
established with precision yet. As it stands out on the reaction
diagram identified as FIG. 1 in appendix, camphor reacts in a
reversible way with ammoniac to produce a hemiaminal derivative.
This hemiaminal derivative of camphor is itself prone to a
number of possible reversible conversions in the presence of
ammoniac and water, and has been impossible to identify by
infrared spectrophotometry yet. However, the Applicant however
thinks that it is the chloride of this hemiaminal derivative of
camphor obtained in the second step of neutralization which is
probably the active principle of the aqueous solution insofar as
the structure of this derivative could effectively mimick the
structure of .beta. family cytokines which are known to act on
monocytes and stimulate the production of IL-1 beta, 6, 8 and
TNF alpha. The complete chemical name of the chloride derivative
is the trimethyl-1,7,7 amino-2 hydroxy-2-bicyclo [1,2,2] heptane
chloride.

The invention will be better understood upon reading what will
follow in a practical example of synthesis and the detailed
description of assays performed up to now by the Applicant.

In another erlenmeyer, 0.9 g of sodium chloride (NaCl) is
dissolved in 79 ml of sterile, non pyrogenic water. The content
of this other erlenmeyer is added to the mixture previously
prepared. The new mixture obtained is vigorously shaken.

The so prepared aqueous solution presents a fluffy precipitate
and supernatant. After three days at room temperature and daily
shaking, the precipitate is completely dissolved.

The aqueous solution is in the form of a clear liquid, with an
ammoniacal smell and an alkaline flavour, the pH of which is
10.4. Then, the pH is adjusted to 7 by introducing 14.9 ml of
nitric acid (HNO.sub.3)N.sub.6.

The final solution obtained is then filtered through a
millipore filter of 0.2 micron.

It is obvious that the basic chemical products used and
previously mentioned comply with the U.S.P. standards and are
manipulated in conditions of total asepsis.

Biological Properties

The biological properties which were obtained with the solution
prepared as described in the preceding example, are the
following: 1) It acts on monocytes in vitro. 2) It transforms
monocytes into mature macrophages in vitro. 3) In vitro again,
transformed macrophages are stimulated to secrete
proinflammatory cytokines. (a) Interleukin-1 beta (IL-1 beta)
known to exert a large variety of effects on differentiation and
function of cells involved in inflammatory processes and immune
responses; and (b) IL-6, 8 alpha and tumor necrosis factor (TNF
alpha), also classified as an immunostimulatory agent and known
to play a role in host resistance against infections and tumor
development.

It is known that the cellular immune response is controlled and
modulated by a family of relatively small molecules called
<<(cytokines)>> which are small protein hormones
playing a role in numerous normal cell functions. Their
functions encompass anti-tumor, anti-viral and anti-bacterial
activities and they induce immune cell growth, differentiation,
activation, chemotactism, adhesion and immunosuppression.

This family of immunomodulators has recently been discovered.
More than 70 different molecules have been identified but it
seems that the family comprises more than 200 members. In other
words, to date, cytokines are only partially known and
characterized.

Known cytokines have been divided into two groups, alpha and
beta, based on their structure. Alpha cytokines include
interleukins, interferons, and other growth factors which
control immune cell proliferation. Beta cytokines include MIP
(Macrophage Inflammatory Proteins), MCP (Monocyte
Chemoattractant Proteins), RANTES, and other proteins which
attract immune cells toward a site of infection or a tumor and,
in doing so, strengthen the activity of the immune system. It
seems that each cytokine molecule is very specific and only
targets a small subpopulation of lymphocytes. In addition,
cytokine fragments as small as 3 to 7 amino acids can bind to
lymphocytes and partially mimick or block the activity of a
complete cytokine molecule.

It is also known that the last three amino acids at the
C-terminal end of beta cytokines are nitrogen-oxygen which bear
a positive charge. It is thus possible that the aqueous solution
according to the invention could exert a stimulatory effect to
secrete cytokines since, as a result of its preparation, it may
contain a small amount of nitrogen-oxygen molecules which look
like and mimick the three amino acid-sequence of the beta
cytokine family. Depending on the required cytokine activity,
the solution according to the invention can either activate the
transformation of monocytes into active macrophages or block the
action of other molecules which paralyse the immune system. In
either case, the result could be reinforcement of the immune
system and the natural defenses to increase tumor cell
destruction.

Results of the Assays Carried Out

Various assays and tests described thereafter were carried out
with vials filled with the aqueous solution prepared according
to the example given hereinabove.

1) Control Tests of the Solution

The aqueous solution prepared according to the invention was
tested. In practice, it should be limpid, clear and volatile,
and leave a dry extract of 63 mg per ml.

2) Sterility Assays

Ten randomly selected vials were incubated at 37 degrees for 48
hours. Then, each vial content was seeded as follows: a) 1 ml of
solution respectively in two tubes of 60 ml containing
thioglycolate medium (Difco) and a tube of 60 ml containing
Sabouraud liquid medium (Difco). b) 0.25 ml of solution
respectively in two tubes of 60 ml containing thioglycolate
medium (Difco) and a tube of 60 ml containing Sabouraud liquid
medium (Difco). c) A thioglycolate tube of group A and a
thioglycolate tube of group B were incubated at 35 degrees for
10 days, all the other tubes being kept for 10 days at room
temperature (about 20 degrees).

All seeded tubes were maintained sterile.

3) Toxicity Assays

Pharmacological assays performed on healthy animals showed an
absence of toxicity, even at very high doses.

Then, one was able to intravenously inject 1 ml of product to a
9-pound rabbit, without being in a position to observe an
unfavourable reaction. In the same way, one was able to inject
0.2 ml of product per pound of body weight to cats and 0.3 ml of
product per pound of body weight to dogs without observing
unfavourable reactions.

By lymphatic delivery, one was able to inject to cats of 10 to
12 pounds up to twice the total dose prescribed in human
therapeutics, for a body weight of 140 to 190 pounds, without
observing unfavourable reactions.

4) Therapeutic Assays

The therapeutic activity of the product was observed for almost
three years in 26 cats and 20 dogs suffering from various
degenerative pathologies as well as viral and bacterial
infections.

Single injected doses varied by one twentieth up to the total
dose proposed above in human therapeutics.

The therapeutic activity of the product was observable in all
cases right from the second day of treatment. This activity
presented itself either by regression of tumor or lymph node
masses, or by resumption to vital functions and return to a
satisfying general state after infectious diseases.

Optimal results were recorded with a posology of 0.075 ml per
pound of body weight, for a 21-day cycle, which has permitted to
establish the previously mentioned posology applicable to human
therapeutics.

5) Pharmacological Assays

As previously indicated, the aqueous solution according to the
invention acts on neoplastic cells and prevents them from
secreting a substance which drives leucocytes and other
phagocytic elements of the organism into a state of negative
chemotactism.

Suppression of this secretion then allows the immune system to
consider the neoplastic formation as a foreign body and destroy
it. Animal testing showed that elimination of lysed tumor masses
occurs through emunctories. Cancer cells thus evacuated present
a nuclear disruption making any mitosis impossible. These
evacuated cells are surrounded by an enormous amount and variety
of very active leucocytes.

Animal testing also showed that hematological constants in
treated animals reached standard levels right from the first
week of treatment.

The aqueous solution according to the invention can be used as
such, preferably by lymphatic delivery.

From a practical point of view, it is worth noting that this
solution can not be exposed to germicidal tube rays (a 2537
angstrom-ray for example).

The landscape of medical science is on the verge of being
radically altered forever by the use of a powerful microscope
(the Somatoscope) developed by Gaston Naessens of Quebec,
Canada, This incredible device reaches magnification levels of
20,000 to 30,000 diameters—well above the 2,500 diameter limit
of conventional microscopes. The sheer magnitude of the
difference in performance gives the appearance of either a gross
violation of the laws of physics, or fraud.

A radical departure in performance from optical and scanning
electron microscopes registers this as a truly great discovery.
Unfortunately, in most fields of science, a great deal of effort
is put forth into listing why something will not work instead of
attempting to duplicate the results. This in turn creates a
situation where what was science, turns into religion where the
orthodox dogma is to be taken on faith, and that which defies
dogma is to be persecuted as heresy. The inertia of a dogma
slows down the rate new discoveries can be made. In the medical
fields, slow acceptance of new ideas can cause many needless
deaths. This is the case with the supermicroscope and the
discoveries of B&hamp, Rife and Naessens.

NOTES

In the 1930s, an obscure and dedicated scientist, Royal Raymond
Rife, had successfully developed the Universal Microscope which
was able to provide amplification levels of 60,000 times without
killing the specimens! Rife was able to observe live viruses and
their reaction to certain stimuli. His observation that bacteria
could change into viruses and viruses could change form,
violated the strongest medical dogma—the germ theory of disease.

In 1934, after learning how to seek out and destroy the
insidious cancer virus, Rife opened a clinic in which he cured
16 out of 16 patients within three months! Working side by side
with some of the most respected researchers in America, Rife
treated patients electronically to kill the virus and then
allowed the body's immune system to restore the body to full
health. Many prestigious (and competent) organisations and
institutions over­saw and verified much of Rife's work during
the 1930s.

Independent physicians using Rife's therapy were treating and
curing as many as 40 patients per day. Other degenerative
conditions and illnesses such as cataracts, herpes and
tuberculosis were found reversible and curable with Rife's
equipment This work was described in various medical journals of
the time as well as the Smithsonian Institution's annual report
and Science magazine. Unfortunately, Rife's success attracted
the attention and wrath of the American Medical Association
(AMA) and the powerful pharmaceutical companies—the organised
opposition of the medical fields.

Although Rife's work was in direct conflict with the orthodox
views of his time, he was supported by many top-rated doctors.
Many of these doctors continued using these devices in secret in
defiance of the AMA and the US government. The carefully
documented records kept by these brave doctors and testimonials
by their patients vindicate Rife's theories. Many of these case
histories and anecdotes about Rife's treatment can be found in
the book, The Cancer Cure that Worked! by Barry Lynes.

The fascinating work of Rife was suppressed and he—like Tesla
before him—joined the ranks of the forgotten inventors of the
early part of this century. It has only been in the past few
years that the general public has begun to develop an awareness
that there is something wrong in the technical world.

MODERN UNIVERSAL MICROSCOPE

What Rife accomplished optically in the 1930s with his
Universal Microscope, Gaston Naessens accomplished with a
combination of optics and electronics in the 1940s in his
Somatoscope. Born on 16 March 1924 in Roubaix, France, Gaston
displayed a predisposition to be an inventor when at the age of
five he built a little moving autolike toy from a Meccano set
and powered it with an alarm clock spring. Later, he built a
home-made motorcycle and a mini-airplane!

While attending the University of Lille, Gaston nearly had his
education disrupted by the German invasion. Fortunately, Gaston
and his fellow students escaped to Nice where they carried on
their education in exile. He was awarded a diploma from the
Union Nationale Scientifique Francaise—a quasi-official
institution under whose auspices the education of the displaced
students continued. He did not bother seeking an equivalency
degree from the de Gaulle government when the French rule was
restored.

At the young age of twenty-one, frustrated by the limitations
of conventional microscopes, Gaston set out to build a superior
microscope. Technical assistance was provided by German
craftsmen from Wetzlar, Germany, who checked out many of
Gaston's original ideas on optics. Privately, Gaston devised the
electrical manipulation of the light source Once the technical
aspects were resolved, Gaston had the body of his microscope
constructed by Barbier-Bemard et Turenne, technical specialists
and defence contractors near Paris.

THEORY OF OPERATION

The Somatoscope mixes light from two orthogonal light sources—a
mercury lamp and a halogen lamp. The light from both sources
enters a glass tube at 90° from each other. As the light waves
beat against each other, a strong carrier wave of light emerges
and travels down the light tube. (It should be noted that two
electromagnetic fields superimposed upon each at 90° is a
classic scalar formation!) As the light travels down the tube,
it passes through a monochromatic filter which forms it into a
mono­chromatic ray. The ray is then passed through a large coil
that sur­rounds the tube. The coil's magnetic field divides the
ray into numerous parallel rays that are then passed through a
Kerr cell which increases the frequency of the rays before being
injected onto the specimen.

FIGURE 1

Two light sources: the first (1) an
incandescent one with a wavelength of about 3600 angstrom, the
second (2) an ultraviolet one with a wavelength of about 2200
angstrom beat against each other to produce a third wavelength
of which passes through a monochromatic filter (3) to produce
a monochromatic ray. This ray is exposed to magnetic fields
(4)-the Zeeman effect- that divides tt to produce
numerous parallel rays (5) that. In turn pass through a Kerr-cell
(6) that increases the frequency. It is this light source,
invisible to the naked eye, that strikes the specimen slides.
The Image is reconstituted by the microscope. Credit: Guide
Resources

The light, which contains the carrier and a mixture of selected
signals in the UV range, stimulates the biological material in
the Somatoscope to the point that the specimens give off their
own light. (Rife referred to this as luminescence.) This is the
key to the ultra-high resolution that has been achieved by
Gaston Naessens.

Conventional microscopes pass light through the specimen which
theoretically limits the resolution of optical microscopes to
the wavelength of light. The finest optical microscopes have
achieved magnification levels of 2,500 diameters. At levels
above this, the resolution is limited by the wavelength of light
and further magnification merely creates a blur! Higher
resolutions have been achieved by microscopes which do not use
lenses, but rather apertures which are smaller than the
wavelength of light. One such microscope engineered in Cornell
University has achieved a resolution of 400 angstroms—a far cry
from the 150 angstroms achieved by Naessens' Somatoscope.

The Somatoscope does not attempt to illuminate the specimen by
passing light through two small objects. Instead, the
illumination source is actually stimulating the specimen to the
point it generates its own light. The light itself expands as it
moves outward and because the specimen itself is generating the
light, the physi­cal restrictions encountered by regular optical
microscopes do not apply. By converting the specimen into a
light source, Gaston Naessens has converted the magnification
problem from one of resolution to that of light detection! At
magnification levels above 5,000 diameters, light levels drop
off the point that film is necessary, but the resolution is
there.

To further research along the lines he has pioneered, Gaston
has developed junior models of his Somatoscope for field use.
These field units allow researchers to obtain illumination and
stimulation of the specimens of the larger unit. The field units
are capable of magnifying 6,000-7,000 diameters, although
routine work will usually be at 3,500-4,000 diameters. The lower
light levels of the higher magnification requires that a lower
level of magnification be accepted for field use in order to
maintain portability in the smaller units. One such unit will be
in use in Colorado Springs at Clifford and Associates. The
Somatoscope has enabled researchers to discover the importance
of colour and its relationship to the material being observed.
The wavelengths of light generated are related to the size of
the object and the health of the cell. For instance, the red
blood cells vary from yellow/green to orange (540 nm to 580 nm)
and white blood cells are rich in blue/violet (490 nm to 510
nm). Exposure to toxic materials, even in minute amounts, causes
significant shifts in colour. Even 'safe' amounts of toxic
materials like mercury and the aluminium in toothpaste cause
significant degradation to red blood cells as I was able to
witness from specimens on a videotape produced from the
Somatoscope. THE SOMATID CYCLE

In a long lost chapter of history in science, a violent
controversy took place in France between the illustrious Louis
Pasteur and Antoine Bechamp, a noted professor of physics,
toxicology, medical chemistry, and biochemistry. Bechamp's work
led him to discover 'microzymas' (tiny ferments) which were
characterised by a host of small bodies in his fermenting
solutions.

After years of study, Bechamp came to the conclusion that these
microzymas were more basic to life than cells. Even with his
crude equipment, he was able to observe that the microzymas
underwent dramatic transformations during their life cycle. This
caused Bechamp to champion the idea that the cause for disease
lay within the body. Pasteur's germ theory held that the cause
came from without Pasteur's outspokenness helped the germ theory
win out and dominate medical philosophy for the past century.

Now, a hundred years later, Gaston Naessens has discovered an
ultramicroscopic, subcellular, living and reproducing
microscopic form which he christened a 'somatid' (tiny body).
This new particle could be cultured outside the bodies of the
host. Naessens also observed that the particle had a pleomorphic
(form-changing) life cycle, and had a sixteen-stage life cycle.
Only the first three stages of the somatid life cycle are
normal. FIGURE 2

Naessens discovered that when the immune system is weakened or
disrupted, the somatids go through the other thirteen stages.
The weakening of the immune system could be brought about by a
number of reasons such exposure to chemical pollution, ionising
radiation, electric fields, poor nutrition, accidents, shock,
depression, and many more.

Incredibly, Naessens' research has resulted in the association
of degenerative diseases (rheumatoid arthritis, multiple
sclerosis, lupus, cancer and AIDS) with the development of forms
in the sixteen-stage pathological cycle. The ability to
associate the disease with specific stages has enabled Naessens
to 'prediagnose' conditions in advance of when they would
clinically appear.

This discovery puts Gaston Naessens at odds with the orthodox
medical philosophy today which has embraced Pasteur's germ
theory wholeheartedly. Naessens' work is repeatable. The ability
to culture somatids is a bellwether to the rewriting of
microbiology!

Naessens stated: "I've been able to establish a life cycle of
forms in the blood that add up to no less than a brand new
understanding of the basis of life. What we're talking about is
an entirely new biology, one out of which has fortunately sprung
practical applications of benefit to sick people, even before
all of its many theoretical aspects have been sorted out" 714X

The research of Gaston Naessens has culminated in the discovery
of 714X—an enzyme which helps the immune system to do its job.
714X is a derivative of camphor and is injected
interlymphatically—a process that the medical fraternity holds
to be impossible. Yet the fact remains that many people have
learned how to administer the medication through lymph nodes.

When properly administered, 714X stabilises and strengthens the
immune system in most cases. This allows the immune system to go
about its normal business in ridding the body of disease. In
other words, cancer is treated like an infection, not a state of
cells.

Like Bechamp and Rife before him, Gaston states unequivocally,
"germs are not the cause of, but the result of, disease".

714X will not help everyone—especially where there has already
been extensive use of chemotherapy and radiation. (Chemotherapy
and radiotherapy wipes out the immune system and other bodily
resources.)

THE SECOND CHANCE

The cancer death toll between 1970 and 1986 was approximately 6
MILLION. Sadly, the conventional treatments of chemotherapy and
radiation therapy are nothing more than slow death sentences
that enrich the cancer industry. Possible miracle cures are
quickly quashed by the FDA (Food & Drug Administration) and
the various medical societies around the world. It is a sad
commentary that in a country that prides itself on freedom,
terminally ill patients cannot make an informed decision to
participate in experimental treatments that may save their
lives.

714X is available in the United States. WRITERS & RESEARCH
is one organisation working closely with the FDA and the IRB
(Institution Review Board) to do work with 714X legally and
ethically. 714X is an injected medication and must beprescribed
by a doctor.